Skip to main content
. 2020 Sep 8;36(9):742–752. doi: 10.1089/aid.2020.0029

Table 3.

Adjusted Odds Ratios for the Association of Insulin Resistance and Measures of Alcohol Use

  AUDIT-C
Phosphatidylethanol
Lifetime drinking history (g)
Any
1–3 (1–2 F)
4–5 (3–5 F)
6–7
8–12
Positive (>8 ng/mL)
Misuse (>250 ng/mL)
>600,00
27,907–171,360
171,361–471,975
480,297–2,056,320
Reference AUDIT-C = 0 Reference PEth = 0 Reference LDH <27,906
Metabolic syndrome 0.76 (0.38, 1.55) 0.94 (0.42, 2.12) 0.56 (0.24, 1.38) 0.43 (0.16, 1.19) 1.33 (0.55, 3.24) 0.56 (0.33, 0.95) 1.02 (0.53, 1.97) 1.71 (0.89, 3.30) 1.46 (0.68, 3.14) 2.58 (1.20, 5.51) 2.43 (1.09, 5.00)
 Men 0.78 (0.29, 2.08) 0.94 (0.28, 2.56) 0.61 (0.19, 1.94) 0.79 (0.20, 2.41) 1.05 (0.33, 3.34) 0.57 (0.29, 1.14) 1.28 (0.58, 2.8) 0.90 (0.39, 2.07) 1.36 (0.46, 4.03) 3.03 (1.06, 8.68) 1.95 (0.68, 5.58)
 Women 1.12 (0.36, 3.47) 2.5 (0.6, 10.4) 0.87 (0.22, 3.4)   4.3 (0.75, 24.7) 0.58 (0.24, 1.42) 0.73 (0.15 3.52) 4.68 (1.36, 23.6) 1.76 (0.55, 5.64) 1.16 (0.32, 4.2) 2.11 (0.56, 7.96)
HOMA-IR 0.60 (0.30, 1.19) 0.80 (0.36, 1.78) 0.49 (0.22, 1.09) 0.71 (0.29, 1.72) 0.46 (0.2, 1.07) 0.8 (0.48, 1.32) 0.64 (0.35, 1.18) 0.96 (0.52, 1.78) 0.90 (0.46, 1.79) 1.03 (0.53, 2.03) 1.05 (0.53, 2.03)
 Men 0.53 (0.20, 1.39) 0.94 (0.32, 2.79) 0.59 (0.18, 1.91) 0.40 (0.13, 1.25) 0.4 (0.13, 1.25) 0.84 (0.43, 1.63) 0.83 (0.40, 1.70) 0.81 (0.37, 1.76) 0.91 (0.36, 2.25) 0.90 (0.36, 2.22) 0.83 (0.33, 2.05)
 Women 0.80 (0.24, 2.65) 0.47 (0.11, 2.05) 0.89 (0.22 3.55) 1.73 (0.28, 10.64) 0.78 (0.15, 4.16) 0.90 (0.36, 2.24) 0.55 (0.11, 2.83) 0.71 (0.2, 2.55) 1.08 (0.31, 3.74) 1.22 (0.34, 4.41) 0.9 (0.25, 3.23)
Triglyceride index 0.98 (0.51, 1.88) 1.07 (0.51, 2.24) 0.84 (0.40, 1.76) 1.07 (0.46, 2.5) 1.02 (0.46, 2.27) 0.98 (0.60, 1.60) 1.1 (0.62, 1.94) 1.16 (0.64, 2.12) 1.15 (0.61, 2.18) 1.32 (0.69, 2.53) 1.44 (0.75, 2.78)
 Men 0.54 (0.21, 1.36) 0.53 (0.19, 1.47) 0.48 (0.17, 1.41) 0.71 (0.23, 2.16) 0.49 (0.17, 1.42) 0.96 (0.51, 1.78) 1.06 (0.55, 2.04) 0.94 (0.46, 1.94) 1.10 (0.48, 2.55) 1.39 (0.60, 3.23) 1.39 (0.59, 3.26)
 Women 2.14 (0.69, 6.63) 2.74 (0.72, 10.5) 1.9 (0.54, 7.04) 1.02 (0.17, 5.83) 3.39 (0.69, 16.6) 0.94 (0.40, 2.20) 1.08 (0.25, 4.71) 1.62 (0.46, 5.7) 1.28 (0.44, 3.7) 0.94 (0.28, 3.13) 1.09 (0.32, 3.71)
McAuley index 0.45 (0.23, 0.86) 0.56 (0.26, 1.20) 0.40 (0.18, 0.88) 0.48 (0.19, 1.22) 0.34 (0.14, 0.84) 0.47 (0.28, 0.81) 0.63 (0.30, 1.30) 0.77 (0.38, 1.55) 1.03 (0.5, 2.12) 0.92 (0.44, 1.93) 0.89 (0.43, 1.84)
 Men 0.22 (0.09, 0.53) 0.30 (0.11, 0.84) 0.13 (0.04, 0.41) 0.27 (0.09, 0.87) 0.19 (0.06, 0.59) 0.38 (0.19, 0.72) 0.52 (0.22, 1.23) 0.68 (0.3, 1.55) 0.94 (0.36, 2.47) 0.68 (0.26, 1.78) 0.70 (0.27, 1.81)
 Women 1.58 (0.44, 5.69) 1.39 (0.32, 6.14) 2.17 (0.53, 8.91) 1.43 (0.19,11.0) 0.74 (0.09, 5.81) 0.72 (0.27, 1.88) 1.9 (0.36, 9.96) 0.49 (0.09, 2.61) 1.11 (0.33, 3.72) 0.9 (0.23, 3.56) 0.47 (0.11, 2.14)

Insulin resistance measured by HOMA-IR, triglycerides index, and McAuley index among men and women in the NOAH Study. All models were adjusted by education, race, BMI, smoking status, viral load, CD4 count, protease inhibitor use, use of statins or metformin, physical activity, and diabetes diagnosis.

Bold values represent higher or lower odds ratio that are statistically significant.

NOAH, New Orleans Alcohol Use in HIV.